NEWS

Jonathan Cohen appointed as Regulatory Affairs Manager

“ It is with great pleasure that I am strengthening the Regulatory Affairs Department, to lead the various projects of…
actus02

Vectans Pharma launches an innovative medecine for treating herpes labialis

About 1 in 10 people suffer from recurring herpes labialis in France. Patients have an average of 3,4 episodes each…
bichat-ph

Vectans Pharma will be attending
Les Entretiens de Bichat

Vectans Pharma will meet Health Care Professionnals during Les Entretiens de Bichat on 8 & 9 October 2018 in Issy-les-Moulineaux.
News-Stefan-Lempereur-2

Dr Stefan Lempereur appointed as Chief Medical Officer

Vectans Pharma announces the appointment of Dr Stefan Lempereur as its new Chief Medical Officer, effective from March 1st 2018.
logo-vectans-bleu

ABOUT VECTANS PHARMA

Vectans Pharma is a European-based pharmaceutical company with a primary focus to target unmet needs in patients with oral pathologies through the acquisition and worldwide commercial development of innovative targeted therapeutics.
Our current portfolio includes Sitavig® and Loramyc®, 2 products approved by FDA and several authorities in Europe, and 1 proprietary innovative galenic technology : Lauriad®.

CONTACT

+33(0)1.41.21.90.16
contact@vectans.com

230 Bureaux de la colline
92213 SAINT CLOUD
France

Copyright © VECTANS PHARMA

Curabitur eleifend neque. consectetur quis, efficitur. dictum ut ipsum sit